Product information
Product name
Siiltibcy 0.5 µg/ml - 0.5 µg/ml
Pack
10 doses (1 ml)
Active ingredient
rdESAT-6 + rCFP-10
CNK Code
5802103
Availability score
0 / 10
Historic availability score
Locked
Product properties
CAS code
ATC code
Company
Serum Life Science Europe
Pharmaceutical form
Solution for injection
Ex-factory price
Authorisation number
EU/1/24/1882/001
GTIN
04069916002030
Delivery mode
M1
Delivery environment
Public
CTI Extended
663916-01
Pharmacist Assessment
Assessment title
Chronically unavailable product
Assessment description
This product is officially available but is structurally not or barely supplied (current score 0/10, historical score 🔒/10). Consider using a structural alternative.
Assessment no alternative
No available alternative found in the system. Consult the physician for a therapeutic alternative.
Equivalent products
Tier A: Direct equivalents
…
Tier B: Galenic alternatives
…
Tier C: Strength alternatives
…
Tier D: ATC equivalents (parallel import)
…
Tier E: Active substances (magistral)
…
Stock overview
Availability in Freemium
- 0 of 18 warehouse locations have stock
- 0 of the 3 wholesalers have stock
Detailed stock insights are available for registered users
Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.
Status history (PharmaStatus)
New on the market
Active
- present
Composition
7 ingredients
Ingredients
| Substance | Type | Strength | CAS |
|---|---|---|---|
|
Substance
|
Type
Active ingredient
|
Strength
0.05 ug/{dose}
|
CAS
|
|
Substance
|
Type
Active ingredient
|
Strength
0.05 ug/{dose}
|
CAS
|
|
Substance
|
Type
Excipient
|
Strength
|
CAS
|
|
Substance
|
Type
Excipient
|
Strength
|
CAS
|
|
Substance
|
Type
Excipient
|
Strength
|
CAS
|
|
Substance
|
Type
Excipient
|
Strength
|
CAS
|
|
Substance
|
Type
Excipient
|
Strength
0.011 mg/{dose}
|
CAS
|
Additional information
Availability statistics
Current status
New on the market
Days unavailable (last year)
0 days
Number of status changes
3
Active supply problems
0
Last change
01/05/2026